Bariatrics clinical trial - B. Braun Medical Inc. - Cefazolin 3gm DUPLEX in Adults (3gCefPK)

Bariatrics

Status:

Startup

ClinicalTrials.gov:

NCT05205486

Bbraun - US-G-H-2101

Drug

Cefazolin 3gm for Injection USP and Dextrose Injection USP

Phase

I

Condition

Infections